Breath Diagnostics, Inc. Achieves FDA Breakthrough Device Status for OneBreath™ Platform for Pneumonia Risk Assessment Breath Diagnostics, Inc. has received FDA Breakthrough Device Designation for its OneBreath™ platform, aiding in pre-operative pneumonia risk assessment with innovative breath analysis technology.

Breath Diagnostics, Inc. Achieves FDA Breakthrough Device Status for OneBreath™ Platform for Pneumonia Risk Assessment #United_States #FDA #Louisville #Breath_Diagnostics #OneBreath™

Revolutionizing Pneumonia Detection: Breath Diagnostics' OneBreath Technology Breath Diagnostics introduces OneBreath™, a groundbreaking technology that predicts pneumonia through exhaled breath analysis. This innovation promises early intervention and better outcomes for patients.

Revolutionizing Pneumonia Detection: Breath Diagnostics' OneBreath Technology #United_States #Louisville #Breath_Diagnostics #OneBreath #pneumonia_detection